BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 24429012)

  • 41. Anticoagulation-related outcomes in patients receiving warfarin after starting levofloxacin or gatifloxacin.
    Mathews S; Cole J; Ryono RA
    Pharmacotherapy; 2006 Oct; 26(10):1446-52. PubMed ID: 16999655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Validation of R-T Estimation for CoaguChek XS INR Results.
    Richter C; Taylor J; Wright J; Fletcher B
    Ann Pharmacother; 2016 Aug; 50(8):645-8. PubMed ID: 27199494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of sulphasalazine potentiating the hypoprothombinemic effect of warfarin resulting in bleeding.
    Hall S; Rindone JP
    J Clin Pharm Ther; 2011 Apr; 36(2):246-8. PubMed ID: 21366655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements?
    Teruel RS; Thue G; Fylkesnes SI; Sandberg S; Kristoffersen AH
    Scand J Prim Health Care; 2017 Sep; 35(3):299-306. PubMed ID: 28776437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
    Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Warfarin therapeutic monitoring: is 70% time in the therapeutic range the best we can do?
    Lader E; Martin N; Cohen G; Meyer M; Reiter P; Dimova A; Parikh D
    J Clin Pharm Ther; 2012 Aug; 37(4):375-7. PubMed ID: 22171554
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Warfarin and royal jelly interaction.
    Lee NJ; Fermo JD
    Pharmacotherapy; 2006 Apr; 26(4):583-6. PubMed ID: 16553520
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Probable warfarin interaction with menthol cough drops.
    Coderre K; Faria C; Dyer E
    Pharmacotherapy; 2010 Jan; 30(1):110. PubMed ID: 20030479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of carbamazepine initiation and discontinuation on antithrombotic control in a patient receiving warfarin: case report and review of the literature.
    Parrish RH; Pazdur DE; O'donnell PJ
    Pharmacotherapy; 2006 Nov; 26(11):1650-3. PubMed ID: 17064211
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levofloxacin and warfarin interaction.
    Jones CB; Fugate SE
    Ann Pharmacother; 2002 Oct; 36(10):1554-7. PubMed ID: 12243605
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extremely prolonged INR associated with warfarin in combination with both trazodone and omega-3 fatty acids.
    Jalili M; Dehpour AR
    Arch Med Res; 2007 Nov; 38(8):901-4. PubMed ID: 17923275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemoptysis due to aspirin treatment alternative to warfarin therapy in a patient with atrial fibrillation.
    Song W; Cao J; Xu Y; Han Z; Wen H; Cui X
    Intern Med; 2015; 54(20):2615-8. PubMed ID: 26466698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolterodine-warfarin drug interaction.
    Colucci VJ; Rivey MP
    Ann Pharmacother; 1999 Nov; 33(11):1173-6. PubMed ID: 10573314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patient-Specific Tailored Intervention Improves INR Time in Therapeutic Range and INR Variability in Heart Failure Patients.
    Gotsman I; Ezra O; Hirsh Raccah B; Admon D; Lotan C; Dekeyser Ganz F
    Am J Med; 2017 Aug; 130(8):982-989. PubMed ID: 28344144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probable warfarin and dapsone interaction.
    Truong T; Haley J
    Clin Appl Thromb Hemost; 2012; 18(1):107-9. PubMed ID: 21890570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apparent interaction between telaprevir and warfarin in a patient with chronic hepatitis C viral infection.
    Gatti DC; Cha A
    Am J Health Syst Pharm; 2012 Dec; 69(23):2062-5. PubMed ID: 23172264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. False prolongation of International Normalized Ratio associated with daptomycin.
    Smith SE; Rumbaugh KA
    Am J Health Syst Pharm; 2018 Mar; 75(5):269-274. PubMed ID: 29472508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL; Harrison D; Germany RE; Adamson PB
    Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.